WSGR logoWSGR logo
WSGR logo
  • Experience
  • People
  • Insights
  • About Us
  • Careers

  • Practice Areas
  • Industries

  • Corporate
  • Intellectual Property
  • Litigation
  • Patents and Innovations
  • Regulatory
  • Technology Transactions

  • Capital Markets
  • Corporate Governance
  • Corporate Life Sciences
  • Derivatives
  • Emerging Companies and Venture Capital
  • Employee Benefits and Compensation
  • Energy and Climate Solutions
  • Executive Advisory Program
  • Finance and Structured Finance
  • Fund Formation
  • Greater China
  • Mergers & Acquisitions
  • Private Equity
  • Public Company Representation
  • Real Estate
  • Restructuring
  • Shareholder Engagement and Activism
  • Tax
  • U.S. Expansion
  • Wealthtech

  • Special Purpose Acquisition Companies (SPACs)

  • Environmental, Social, and Governance

  • AI and Data Center Infrastructure
  • Energy Regulation and Competition
  • Project Development and M&A
  • Project Finance and Tax Credit Transactions
  • Sustainability and Decarbonization
  • Transportation Electrification

  • U.S. Expansion Library and Resources

  • Post-Grant Review
  • Trademark and Advertising

  • Antitrust Litigation
  • Arbitration
  • Board and Internal Investigations
  • Class Action Litigation
  • Commercial Litigation
  • Consumer Litigation
  • Corporate Governance Litigation
  • Employment Litigation
  • Executive Branch Updates
  • Government Investigations
  • Internet Strategy and Litigation
  • Patent Litigation
  • Securities Litigation
  • State Attorneys General
  • Supreme Court and Appellate Practice
  • Trade Secret Litigation
  • Trademark and Copyright Litigation
  • Trial
  • White Collar Crime

  • Advertising, Promotions, and Marketing
  • Antitrust and Competition
  • Committee on Foreign Investment in the U.S. (CFIUS)
  • Communications
  • Data, Privacy, and Cybersecurity
  • Export Control and Sanctions
  • FCPA and Anti-Corruption
  • FDA Regulatory, Healthcare, and Consumer Products
  • Federal Trade Commission
  • Fintech and Financial Services
  • Government Contracts
  • National Security and Trade
  • Payments
  • State Attorneys General
  • Strategic Risk and Crisis Management
  • Tariffs, Customs, and Import Compliance

  • Antitrust and Intellectual Property
  • Antitrust Civil Enforcement
  • Antitrust Compliance and Business Strategy
  • Antitrust Criminal Enforcement
  • Antitrust Litigation
  • Antitrust Merger Clearance
  • European Competition Law
  • Third-Party Merger and Non-Merger Antitrust Representation

  • Anti-Money Laundering
  • Foreign Ownership, Control, or Influence (FOCI)
  • Team Telecom

  • AI in Healthcare
  • Animal Health
  • Artificial Intelligence and Machine Learning
  • Aviation
  • Biotech
  • Blockchain and Cryptocurrency
  • Clean Energy
  • Climate and Clean Technologies
  • Communications and Networking
  • Consumer Products and Services
  • Data Storage and Cloud
  • Defense Tech
  • Diagnostics, Life Science Tools, and Deep Tech
  • Digital Health
  • Digital Media and Entertainment
  • Electronic Gaming
  • Fintech and Financial Services
  • FoodTech and AgTech
  • Global Generics
  • Internet
  • Life Sciences
  • Medical Devices
  • Mobile Devices
  • Mobility
  • NewSpace
  • Quantum Computing
  • Semiconductors
  • Software

  • Offices
  • Country Desks
  • Events
  • Community
  • Our Diversity
  • Sustainability
  • Our Values
  • Board of Directors
  • Management Team

  • Austin
  • Boston
  • Boulder
  • Brussels
  • Century City
  • Hong Kong
  • London
  • Los Angeles
  • New York
  • Palo Alto
  • Salt Lake City
  • San Diego
  • San Francisco
  • Seattle
  • Shanghai
  • Washington, D.C.
  • Wilmington, DE

  • Law Students
  • Judicial Clerks
  • Experienced Attorneys
  • Patent Agents
  • Business Professionals
  • Alternative Legal Careers
  • Contact Recruiting
Insights
Type
People
Practices
Industries
From Date
To Date
Reset Search

Search Results

Client Highlights

3.18.26

Wilson Sonsini Advises XENOM on $15 Million Seed Round and Commercial Agreement with Rogue Fitness
On February 27, 2026, XENOM announced it has officially launched with a $15 million seed financing to create stadium-scale global events. The round was led by WndrCo and Rogue Fitness. Additionally, Rogue Fitness will serve as XENOM’s official equipment supplier. Wilson Sonsini Goodrich & Rosati advised XENOM on the transactions.
Client Highlights

7.14.25

Wilson Sonsini Advises Windsurf on Acquisition by Cognition AI
On July 14, 2025, Cognition announced that it has signed a definitive agreement to acquire Windsurf, the agentic IDE. The acquisition includes Windsurf's IP, product, trademark, and brings the full Windsurf team to Cognition. Wilson Sonsini advised Windsurf on the transaction.
Client Highlights

4.17.25

Wilson Sonsini Advises Crux on $50 Million Series B
On April 16, 2025, Crux, a capital markets technology company for the clean economy, announced that it has raised $50 million in Series B funding led by Lowercarbon Capital. Existing investors Andreessen Horowitz (a16z), Ardent Venture Partners, CIV, New System Ventures, and The Three Cairns Group participated in the round. These investors are joined by new investors Liberty Mutual Strategic Ventures, MassMutual Ventures, and OMERS Ventures. Venture capital firms Acrew Capital and Giant Ventures also joined the round. Wilson Sonsini Goodrich & Rosati advised Crux on the transaction.

The Series B round brings Crux’s total funding to over $77 million and will help drive its next phase of growth. The company plans to use the new capital to meet its mission of supporting developers, manufacturers, investors, and lenders through all stages of capital formation. This funding round comes on the heels of Crux’s latest platform innovation: its debt capital marketplace which opens access to a range of debt products alongside Crux’s powerful transferable tax credit marketplace.

The Wilson Sonsini team that advised Crux on the transaction includes:
Client Highlights

2.04.25

Wilson Sonsini Advises TravelPerk on $200 Million Series E Financing
On January 28, 2025, TravelPerk, a business travel platform based in Barcelona, Spain, and Zurich, Switzerland, raised $200 million in Series E funding. The oversubscribed round doubled the company's valuation to $2.7 billion. The funding was led by Atomico and EQT Growth, with participation from Noteus Partners and existing investors, including Kinnevik and General Catalyst. TravelPerk was advised by Wilson Sonsini Goodrich & Rosati during the transaction.
Client Highlights

1.23.24

Wilson Sonsini Advises Silo Technologies on $35 Million Investment
On December 13, 2023, Silo Technologies, a provider of modern capital and technology solutions for the food supply chain, announced the closing of a $35 million investment from Koch Disruptive Technologies. The investment follows Silo's $32 million Series C round. Wilson Sonsini Goodrich & Rosati advised Silo Technologies on the transaction.
Client Highlights

7.18.23

Wilson Sonsini Advises Silo on $32 Million Series C Financing
On July 12, 2023, Silo Technologies, the leading provider of modern technology solutions for the food supply chain, announced the closing of a $32 million Series C financing led by Koch Disruptive Technologies alongside existing investors Andreessen Horowitz, Haystack Capital, Tribe Capital, Collate Capital, and Moore Capital. Wilson Sonsini Goodrich & Rosati advised Silo in the transaction.
Client Highlights

9.16.22

Firm Advises Redesign Health on $65 Million Series C Financing
On September 13, 2022, Redesign Health, a New York City-based company that builds other healthcare start-ups, closed a $65 million Series C funding round. The funding was led by General Catalyst, with other investors including CVS Health Ventures, UPMC Enterprises, Eden Global Partners, Euclidean Capital, Samsung Next, TriplePoint Capital, and Declaration Partners also participating. Wilson Sonsini Goodrich & Rosati advised Redesign Health on the transaction.

Founded in 2018, Redesign Health researches, assembles, brands, and launches healthcare start-ups by tapping into its team of entrepreneurs, healthcare industry operators, business analysts, and investors. To date, Redesign Health has launched more than 40 companies, including Ever/body, which focuses on cosmetic dermatology; cancer-care company Jasper; and metabolic health company Calibrate. According to the company’s founder and CEO, Brett Shaheen, Redesign Health plans to create more than 25 companies this year alone. The proceeds from the latest funding will benefit Redesign Health’s own operations and platform, rather than being doled out to the operating companies it has founded.

The Wilson Sonsini team that advised Redesign Health on the financing included Megan Baier, Seth Helfgott, Rob Broderick, Josh Bronstein, and Daniel Xo.

For more information, please see this Fast Company article.
Client Highlights

6.29.21

Wilson Sonsini Advises Density on Acquisition of Nashi
On June 29, 2021, Density Inc., the leader in business solutions for the built environment, announced that it has acquired Nashi, a unique, fast, and elegant system for allocating, managing, and reserving space. Wilson Sonsini Goodrich & Rosati advised Density on the transaction.

Nashi’s product will become Workplace by Density, and their world-class team will join Density’s San Francisco office and broader distributed team. The Workplace application expedites the space allocation and planning process, integrates seamlessly with HR systems, and allows workplace admins to drag and drop entire teams onto the spaces they have permission to reserve once they return to the office. According to Density CEO Andrew Farah, “Workplace is not only modern software for allocating areas to business units and people, it's also an easy system for employees to reserve a desk near their colleague, book space with their team, and otherwise get more from their place of work.”
  • people
  • insights
  • about us
  • careers
  • Binder
  • Alumni
  • Mailing List Signup
  • Client FTP Portal
  • Privacy Policy
  • Terms of Use
  • Accessibility
WSGR logo
Twitter
LinkedIn
Facebook
Instagram
Youtube
Copyright © 2026 Wilson Sonsini Goodrich & Rosati. All Rights Reserved.